Opioid Usage
FDA Approves DNA Cheek Swab Test to ID Patients at High Risk for Opioid Addiction
In clinical trials, the test accurately assessed a raised risk for addiction 83 percent of the time The U.S. Food and Drug Administration has approved a first-of-its-kind test — the AvertD test — that uses DNA swabbed from a patient’s cheek to determine if they have a combination of genetic variants associated with an elevated...
Medical Cannabis Laws Seem Not to Have Affected Opioid, Nonopioid Therapy
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain. Medical cannabis laws seem not to have important effects on the receipt of opioid or nonopioid pain treatment, according to a study published online July 4 in the Annals of Internal Medicine. Emma E. McGinty, Ph.D., from Weill Cornell...
FDA Updates Prescribing Information and Guidelines for Opioid Analgesics
The Food and Drug Administration has upgraded its prescribing information and guidelines in light of data on the contribution of prescribed opioid medicines to overall opioid-related morbidity and mortality. Opioid drugs are potent analgesics prescribed to counter pain that is not responding to other analgesics or treatments. However, these medications are associated with significant safety...
FDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses
The spray can already be obtained without a prescription, but currently buyers must get it from a pharmacist. The U.S. Food and Drug Administration on Wednesday approved the over-the-counter (OTC) use of naloxone (Narcan). “Today’s approval of OTC naloxone nasal spray will help improve access to naloxone, increase the number of locations where it’s available...
FDA Panel Considers Making Opioid Antidote Drug Available Without Prescription
Key Takeaways Advisers to the U.S. Food and Drug Administration will discuss over-the-counter purchase of a nasal spray that can reverse an opioid overdose The spray — generic naloxone hydrochloride — can already be obtained without a prescription, but currently buyers must get it from a pharmacist Experts say removing that requirement could remove some...
Rate of Opioid Rx at Discharge From Emergency Department Declining
Decrease seen in rate and percentage of emergency department visits with opioid prescribed at discharge from 2017-2018 to 2019-2020 From 2017-2018 to 2019-2020, there has been a decrease in opioid prescribing at discharge from the emergency department, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National...
FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone
The U.S. Food and Drug Administration today announced it is requiring that labeling for opioid pain medicine and medicine to treat opioid use disorder (OUD) be updated to recommend that as a routine part of prescribing these medicines, health care professionals should discuss the availability of naloxone with patients and caregivers, both when beginning and...
More Medical News
